M RE6 (Ropinirole Hydrochloride Extended-Release 6 mg)
Pill with imprint M RE6 is White, Round and has been identified as Ropinirole Hydrochloride Extended-Release 6 mg. It is supplied by Mylan Pharmaceuticals Inc..
Ropinirole is used in the treatment of restless legs syndrome; periodic limb movement disorder; parkinson's disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Ropinirole 6 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for M RE6
Ropinirole Hydrochloride Extended-Release
- Imprint
- M RE6
- Strength
- 6 mg
- Color
- White
- Size
- 10.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Dopaminergic antiparkinsonism agents
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC)
- 00378-4092
- Inactive Ingredients
-
lactose anhydrous,
ferrosoferric oxide,
silicon dioxide,
ethylcelluloses,
FD&C Red No. 40,
FD&C Yellow No. 6,
hypromelloses,
magnesium stearate,
microcrystalline cellulose,
propylene glycol,
FD&C Blue No. 2
Note: Inactive ingredients may vary.
Related Images for "M RE6"
More about ropinirole
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 289 Reviews
- Drug class: dopaminergic antiparkinsonism agents
- FDA Alerts (1)
Consumer resources
- Patient Information
- Ropinirole (Advanced Reading)
- Ropinirole Extended-Release Tablets
- Ropinirole Tablets
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.